Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950170-24-127116
Filing Date
2024-11-14
Accepted
2024-11-14 16:30:24
Documents
63
Period of Report
2024-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q cycn-20240930.htm   iXBRL 10-Q 1712763
2 EX-31.1 cycn-ex31_1.htm EX-31.1 11854
3 EX-31.2 cycn-ex31_2.htm EX-31.2 11857
4 EX-32.1 cycn-ex32_1.htm EX-32.1 6413
5 EX-32.2 cycn-ex32_2.htm EX-32.2 6416
  Complete submission text file 0000950170-24-127116.txt   7052598

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT cycn-20240930.xsd EX-101.SCH 1106510
65 EXTRACTED XBRL INSTANCE DOCUMENT cycn-20240930_htm.xml XML 1165470
Mailing Address 301 BINNEY STREET CAMBRIDGE MA 02142
Business Address 301 BINNEY STREET CAMBRIDGE MA 02142 617-621-7722
Cyclerion Therapeutics, Inc. (Filer) CIK: 0001755237 (see all company filings)

EIN.: 831895370 | State of Incorp.: MA | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38787 | Film No.: 241463109
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)